Diurnal blood pressure variation in pheochromocytoma, primary aldosteronism and Cushing's syndrome

Journal of Human Hypertension

Volumn 18, Issue 2, 2004, Pages 107-111

  Zelinka, T ^a   Strauch B ^a   Pecen, L ^b   Widimsky Jr J ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF COMPUTER SCIENCE   (Czech Republic)

Author keywords

Circadian blood pressure rhythm; Cushing's syndrome; Pheochromocytoma; Primary aldosteronism

Indexed keywords

ALDOSTERONE; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT;

ADENOMA; ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CIRCADIAN RHYTHM; CONTROLLED STUDY; CUSHING SYNDROME; DIASTOLIC BLOOD PRESSURE; ESSENTIAL HYPERTENSION; EXCISION; HORMONE SYNTHESIS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; PHEOCHROMOCYTOMA; PRIMARY HYPERALDOSTERONISM; STATISTICAL ANALYSIS; SYSTOLIC BLOOD PRESSURE;

ADRENAL GLAND NEOPLASMS; ADULT; AGED; ALDOSTERONE; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CASE-CONTROL STUDIES; CIRCADIAN RHYTHM; CUSHING SYNDROME; FEMALE; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; MALE; MIDDLE AGED; PHEOCHROMOCYTOMA;

EID: 1342326728     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001644     Document Type: Article

References (21)

1. Middeke M, Schrader J. Nocturnal blood pressure in normotensive subjects and those with white coat, primary and secondary hypertension. BMJ 1994; 308: 630-632.
2. Spieker C, Barenbrock M, Rahn KH, Zidek W. Circadian blood pressure variations in endocrine disorders. Blood Pressure 1993; 2: 35-39.
3. Imai Y et al. Altered circadian blood pressure rhythm in patients with Cushing's syndrome. Hypertension 1988; 12: 11-19.
4. Tanaka T et al. Circadian rhythm of blood pressure in primary aldosteronism and renovascular hypertension - Analysis by the cosinor method. Jpn Circ J 1984; 47: 788-794.
5. Uzu T et al. Changes in the circadian rhythm of blood pressure in primary aldosteronism in response to dietary sodium restriction and adrenalectomy. J Hypertens 2000; 16: 1745-1748.
6. Zelinka T, Widimský J. Twenty-four hour blood pressure profile in subjects with different subtypes of primary aldosteronism. Physiol Res 2001; 50: 51-57.
7. Padfield PL, Jyothinagaram SG, McGinley IM, Watson DM. Reversal of the relationship between heart rate and blood pressure in pheochromocytoma: A non-invasive diagnostic approach? J Hum Hypertens 1991; 5: 501-504.
8. Dabrowska B et al. Effect of removal of pheochromcytoma on diurnal variability of blood pressure, heart rhythm and excretion of catecholamines. J Hum Hypertens 1990; 4: 397-399.
9. Van Eps RGS et al. Diurnal variation of blood pressure in patients with catecholamine-producing tumors. Am J Hypertens 1994; 7: 492-497.
10. Imai Y et al. Hypertensive episodes and circadian fluctuations of blood pressure in patients with pheochromocytoma: Studies by long-term blood pressure monitoring based on a volume-oscillometric method. J Hypertens 1988; 6: 9-15.
11. Imai Y et al. Circadian blood pressure variation in patients with renovascular hypertension or primary aldosteronism. Clin Exper Hypertens 1992: A14: 1141-1167.
12. Penzo M et al. In primary aldosteronism the circadian blood pressure rhythm is similar to that in primary aldosteronism. Clin Exper Hypertens 1994; 16: 659-674.
13. Rabbia F et al. Fourier analysis of circadian blood pressure profile in secondary hypertension. J Hum Hypertens 1997; 11: 295-299.
14. Mansoor GA, White WB. Circadian blood pressure variation in hypertensive subjects with primary aldosteronism. Hypertension 1998; 31: 843-847.
15. Munakata M et al. Altered sympathetic and vagal modulations of the cardiovascular system in patients with pheochromocytoma. Am J Hypertens 1999; 12: 572-580.
16. Streeten DHP, Anderson Jr GH. Mechanisms of orthostatic hypotension and tachycardia in patients with pheochromocytoma. Am J Hypertens 1996; 9: 760-769.
17. Zelinka T, Widimský J, Weisserova J. Diminished circadian blood pressure rhythm in patients with asymptomatic normotensive pheochromocytoma. Physiol Res 2001; 50: 631-634.
18. Bravo EL. Evolving concepts in the pathophysiology, diagnosis and treatment of pheochromocytoma. Endocr Rev 1994; 15: 356-368.
19. Wu KD et al. Dopaminergic modulation of aldosterone secretions on changes of sodium intake in aldosterone-producing adenoma. Am J Hypertens 2002; 15: 609-614.
20. Kimura Y, Kawamura M, Onedora S, Hiramori K. Controlled study of circadian rhythm of blood pressure in patients with aldosterone-producing adenoma compared with those with essential hypertension. J Hypertens 2000; 18: 21-25.
21. Whitworth JA, Mangos GJ, Kelly JJ. Cushing, cortisol and cardiovascular disease. Hypertension 2000; 36: 912-916.